Lichen planus: a comprehensive evidence‐based analysis of medical treatment

H Husein‐ElAhmed, U Gieler… - Journal of the European …, 2019 - Wiley Online Library
Lichen planus (LP) is a chronic‐relapsing inflammatory skin disease. Although many drugs
have been used for the management of LP, some of them lack the backup by strong …

Primary cicatricial alopecia: lymphocytic primary cicatricial alopecias, including chronic cutaneous lupus erythematosus, lichen planopilaris, frontal fibrosing alopecia …

C Bolduc, LC Sperling, J Shapiro - Journal of the American Academy of …, 2016 - Elsevier
Both primary and secondary forms of cicatricial alopecia have been described. The hair
follicles are the specific target of inflammation in primary cicatricial alopecias. Hair follicles …

Treatment of cutaneous lichen planus (part 2): a review of systemic therapies

Y Thandar, R Maharajh, F Haffejee… - Journal of …, 2019 - Taylor & Francis
Background: Although numerous medications are available for the treatment of cutaneous
lichen planus (CLP), recurrence is common and there is a lack of evidence of efficacy of …

[HTML][HTML] Comparison of therapeutic effect of low-dose low-molecular-weight heparin (enoxaparin) vs. oral prednisone in treatment of patients with lichen planus; A …

F Iraji, A Asilian, A Saeidi, AH Siadat… - Advanced Biomedical …, 2013 - journals.lww.com
Background: The aim of this study was to evaluate and compare the therapeutic efficacy of
subcutaneous enoxaparin versus oral prednisone (as a standard treatment) in patients with …

[HTML][HTML] Acitretin for the management of generalized cutaneous lichen planus

A Vazirnia, PR Cohen - Dermatology Online Journal, 2014 - escholarship.org
Background: Lichen planus is an inflammatory disease that affects the skin, the oral mucosa,
or both. Generalized cutaneous lichen planus may pose a therapeutic challenge for …

Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients

L Shavit, M Lifschitz, S Lee, I Slotki - International urology and nephrology, 2011 - Springer
Background Enoxaparin, a low molecular weight heparin, has been shown to be a safe and
effective anticoagulant to prevent clotting in the extracorporeal circulation during …

[HTML][HTML] Therapeutic potential of enoxaparin in lichen planus: exploring reasons for inconsistent reports

RP Patel, MD Shastri, LC Ming, STR Zaidi… - Frontiers in …, 2018 - frontiersin.org
Lichen planus (LP) is an uncommon mucocutaneous inflammatory condition, that is
immunologically mediated, typically pruritic and often recurs. The currently advocated …

The effectiveness of treatment with enoxaparin in lichen planus

D Uçmak, G Balcı, M Harman - Journal of Clinical and Experimental …, 2012 - dergipark.org.tr
Objectives: As it is known, the low doses of Heparin's analogues have the antiproliferative
and immunomodulator activities. This research aims to evaluate the activity of enoxaparin by …

[PDF][PDF] Treatment of recalcitrant lichen planus with low molecular weight heparin (Enoxaparin): a case series study among Iraqi patients

WA Ameen, ZS Alfadhily - Med J Babylon, 2011 - iasj.net
Lichen planus (LP) is a unique, common, pruritic, inflammatory disease of the skin, mucous
membranes and hair follicles. The exact pathogenesis of LP is unknown, but it is evident that …

Efficacy of low dose low molecular weight heparin in the treatment of cutaneous lichen planus

MSI Khan, MN Uddin, MOR Shah… - Journal of Armed …, 2013 - banglajol.info
Introduction: Lichen planus is a common pruritic, inflammatory disease of the skin, mucous
membranes, nail and hair follicles. Low dose low molecular weight heparin is administered …